共 25 条
[1]
Martindale, The Complete Drug Reference, pp. 1758-1789, (2005)
[2]
Roseman T.J., Yalkowsky S.H., Physicochemical properties of prostaglandin F2alpha (tromethamine salt): Solubility behavior, surface properties, and ionization constants, J Pharm Sci, 62, pp. 1680-1685, (1973)
[3]
Gu L., Strickley R.G., Preformulation salt selection. Physical property comparisons of the tris(hydroxymethyl)aminomethane (THAM) salts of four analgesic/antiinflammatory agents with the sodium salts and the free acids, Pharm Res, 4, pp. 255-257, (1987)
[4]
Borsa F., Leroy A., Fillastre J.P., Godin M., Moulin B., Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults, Antimicrob Agents Chemother, 32, pp. 938-941, (1988)
[5]
Gwak H.S., Chun I.K., Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin, Int J Pharm, 236, pp. 57-64, (2002)
[6]
Loftsson T., Fridriksdottir H., Stabilizing effect of tris(hydroxymethyl) aminomethane on N-nitrosoureas in aqueous solutions, J Pharm Sci, 81, pp. 197-198, (1992)
[7]
Rabasco A.M., Caraballo I., Fernandez A.M., Formulation factors affecting thimerosal stability, Drug Dev Ind Pharm, 19, pp. 1673-1691, (1993)
[8]
McGloughlin R.M., Corrigan O.I., Dissolution characteristics of benzoic acid-TRIS mixtures, Int J Pharm, 82, pp. 135-143, (1992)
[9]
El Sayed G.M., Role of tromethamine as a dissolution and bioavailability enhancer of oral glibenclamide, STP Pharma Sci, 8, pp. 169-173, (1998)
[10]
Gabr K.E., Borg T.M., Characterization of hydrochorothiazidetrometamol mixtures: Formulation of fast release and soluble tablets, Pharm Ind, 61, pp. 281-285, (1999)